COMPASS Pharma
ActiveSummary
COMPASS Pharma has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €236,480 and a net result of €39,042. Equity is growing by about 12% per year across the filed financial years. Its solvency ranks better than 50% of 39,131 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
04-05
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
06-06
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format
2024
07-06
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format
2023
04-06
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format
2022
31-12
Financial
Liquidity more than 10 timescurrent ratio 52.03
Current ratio from 5.00 to 52.03; short-term debt falls from €67,125 to €6,392.
05-06
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format
2021
12-07
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format
2020
31-12
Financial
Equity above €200,000equity €206,878 ▲51.9%
A profit in every financial year since 2018 builds equity to €206,878.
24-08
NBB filing
Annual accounts filed
financial year 2019 · abbreviated format · 24 days late
2019
31-12
Financial
Liquidity more than triplescurrent ratio 11.54
Current ratio from 3.19 to 11.54; short-term debt falls from €43,499 to €12,194.
28-05
NBB filing
Annual accounts filed
financial year 2018 · abbreviated format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.